Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Dhall

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Thrombosis Research|October 15, 1985
Physiological studies on fibrin network structureG A Shah, C H Nair, D P Dhall
The British Journal of Surgery|June 1, 1972
Routine operative arteriography in arterial embolectomyG E Mavor, M G Walker, D P Dhall
Thrombosis Research|November 15, 1993
Platelets and the permeability of fibrin network developed in human plasmaJ M van Gelder, C H Nair, D P Dhall
Biorheology|May 1, 1994
The significance of red cell surface area to the permeability of fibrin networkJ M van Gelder, C H Nair, D P Dhall
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 1, 1996
Colloid determination of fibrin network permeabilityJ M van Gelder, C H Nair, D P Dhall
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
The permeability of fibrin network developed in human plasmaJ M van Gelder, C H Nair, D P Dhall
Thrombosis Research|April 1, 1996
Erythrocyte aggregation and erythrocyte deformability modify the permeability of erythrocyte enriched fibrin networkJ M van Gelder, C H Nair, D P Dhall
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1994
Complement activation: a new participant in the modulation of fibrin gel characteristics and the progression of atherosclerosis?E A Shats-Tseytlina, C H Nair, D P Dhall
Thrombosis Research|September 1, 1993
Effects of Poloxamer 188 on fibrin network structure, whole blood clot premeability and fibrinolysisJ M van Gelder, C H Nair, D P Dhall
Thrombosis Research|November 15, 1991
Studies on fibrin network structure in human plasma. Part II--Clinical application: diabetes and antidiabetic drugsC H Nair, A Azhar, J D Wilson, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Thrombosis Research|October 15, 1985
Physiological studies on fibrin network structureG A Shah, C H Nair, D P Dhall
The British Journal of Surgery|June 1, 1972
Routine operative arteriography in arterial embolectomyG E Mavor, M G Walker, D P Dhall
Thrombosis Research|November 15, 1993
Platelets and the permeability of fibrin network developed in human plasmaJ M van Gelder, C H Nair, D P Dhall
Biorheology|May 1, 1994
The significance of red cell surface area to the permeability of fibrin networkJ M van Gelder, C H Nair, D P Dhall
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 1, 1996
Colloid determination of fibrin network permeabilityJ M van Gelder, C H Nair, D P Dhall
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
The permeability of fibrin network developed in human plasmaJ M van Gelder, C H Nair, D P Dhall
Thrombosis Research|April 1, 1996
Erythrocyte aggregation and erythrocyte deformability modify the permeability of erythrocyte enriched fibrin networkJ M van Gelder, C H Nair, D P Dhall
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1994
Complement activation: a new participant in the modulation of fibrin gel characteristics and the progression of atherosclerosis?E A Shats-Tseytlina, C H Nair, D P Dhall
Thrombosis Research|September 1, 1993
Effects of Poloxamer 188 on fibrin network structure, whole blood clot premeability and fibrinolysisJ M van Gelder, C H Nair, D P Dhall
Thrombosis Research|November 15, 1991
Studies on fibrin network structure in human plasma. Part II--Clinical application: diabetes and antidiabetic drugsC H Nair, A Azhar, J D Wilson, et al.
Pageof 5